Overall Rank: 3
Category: Medical Devices
Category Rank: 2
- Top HealthTech Company of 2022
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. As the pioneer of many products considered industry standard, including the transcatheter aortic valve replacement, Edwards’ products are sold in approximately 100 countries around the world. Founded by engineer Miles “Lowell” Edwards in 1958, the company has 16,000 employees around the world with manufacturing operations in North America, Europe, Singapore, and the Caribbean.
The Edwards Lifesciences Foundation supported more than 250 global charities in 2021 and continued its work with Every Heartbeat Matters, the Foundation’s primary philanthropic initiative, to improve the lives of 2.5 million additional underserved structural heart and critical care patients by the end of 2025.
To advance social equity, Edwards established a Social Impact Investment Fund with $100 million to support economic development in predominantly Black and underserved communities in the U.S. When Edwards was established as a separate company from Baxter in 2000, the company was formed around a credo which serves as a reminder to always put patients first, and that as a company Edwards will remain committed to making a positive impact on the quality of life for patients around the world.
Electronic Data Interchange (EDI)
Edwards Lifesciences offers Electronic Data Interchange (EDI) as a way to streamline the order-to-procurement business processes. One of our two eCommerce channels, EDI provides a fully integrated order-to-invoice experience.
Heart Valve Technologies
Dedicated to improving the lives of patients with structural heart disease, Edwards Lifesciences commitment to transformational heart valve technology began in 1960 with the first commercially available heart valve. Edwards has continued to meaningfully advance heart valve therapy, and, more than 50 years later, we remain a global leader in this field. Their offerings include tissue replacement heart valves and repair products, as well as transcatheter heart valves for those patients considered at high or greater risk for conventional valve replacement.
Critical Care Technologies
Edwards has been advancing the care of the acutely ill for more than 40 years. Starting with the development of Swan-Ganz advanced hemodynamic monitoring devices for measuring cardiovascular performance in high-risk surgical and critically ill patients, Edwards continues to evolve to less-invasive and noninvasive devices to provide valuable hemodynamic insight for an expanded patient population. Edwards has continued to advance hemodynamic monitoring platforms to enable proactive clinical decisions for surgical, anesthesia and critical care clinicians. Edwards is focused on helping clinicians enhance knowledge and standardize practice to improve the quality and efficiency of care. Edwards provides evidence-based programs such as Enhanced Surgical Recovery Program that support the implementation and compliance to protocolized care pathways in the OR and ICU.